Kamada Ltd.

KMDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.74

-$0.11 (-1.24%)

At close: Sep 21, 2026, 4:00 PM ET

$8.68

-$0.06 (-0.69%)

Pre-market: Sep 22, 2026, 5:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

-1.24%

(1D)

Rating

Updated: Sep 12, 2026

62.5

Fundamentals Strong

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $504.25M

1D Range

8.73 8.95

52W Range

6.50 9.35

Valuation (TTM)

PE 23

PB 1.87

EV/EBITDA 10.62

Valuation (NTM)

Forward PE 14.71

Forward PEG 1.03

Price Target $15

Cash Flow

FCF Yield 5.3%

SBC Adj. FCF Yield 5.1%

SBC Impact -3.5%

Margins

Gross Margin 40.8%

Operating Margin 14.5%

FCF Margin 13.8%

Growth (CAGR)

Revenue 3Y | 5Y 9.6% | 10.6%

Dil EPS 3Y | 5Y 72.1% | 7.1%

FCF 3Y | 5Y 60.2% | 40.4%

Returns

ROA 5.8%

ROE 8.4%

ROIC 6.9%

Financial Health

Net Cash

$70.13M

Current Ratio 4.06

Interest Coverage 26.84

Dividends

Div Yield 1.95%

Payout Ratio 44.7%

FCF Payout Ratio 53.5%

All Key Statistics

Loading financial charts...

Profile

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 462

IPO Date May 30, 2013

Website www.kamada.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$15

Upside

+71.62%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞